| Literature DB >> 27741255 |
Tsai-Wen Wan1,2, Olga E Khokhlova1,3,4, Yasuhisa Iwao1,3, Wataru Higuchi5, Wei-Chun Hung6, Ivan V Reva1,7, Olga A Singur8, Vladimir V Gostev9, Sergey V Sidorenko9, Olga V Peryanova3,4, Alla B Salmina10, Galina V Reva7, Lee-Jene Teng2, Tatsuo Yamamoto1,3,7.
Abstract
ST8/SCCmecIV community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has been a common threat, with large USA300 epidemics in the United States. The global geographical structure of ST8/SCCmecIV has not yet been fully elucidated. We herein determined the complete circular genome sequence of ST8/SCCmecIVc strain OC8 from Siberian Russia. We found that 36.0% of the genome was inverted relative to USA300. Two IS256, oppositely oriented, at IS256-enriched hot spots were implicated with the one-megabase genomic inversion (MbIN) and vSaβ split. The behavior of IS256 was flexible: its insertion site (att) sequences on the genome and junction sequences of extrachromosomal circular DNA were all divergent, albeit with fixed sizes. A similar multi-IS256 system was detected, even in prevalent ST239 healthcare-associated MRSA in Russia, suggesting IS256's strong transmission potential and advantage in evolution. Regarding epidemiology, all ST8/SCCmecIVc strains from European, Siberian, and Far Eastern Russia, examined had MbIN, and geographical expansion accompanied divergent spa types and resistance to fluoroquinolones, chloramphenicol, and often rifampicin. Russia ST8/SCCmecIVc has been associated with life-threatening infections such as pneumonia and sepsis in both community and hospital settings. Regarding virulence, the OC8 genome carried a series of toxin and immune evasion genes, a truncated giant surface protein gene, and IS256 insertion adjacent to a pan-regulatory gene. These results suggest that unique single ST8/spa1(t008)/SCCmecIVc CA-MRSA (clade, Russia ST8-IVc) emerged in Russia, and this was followed by large geographical expansion, with MbIN as an epidemiological marker, and fluoroquinolone resistance, multiple virulence factors, and possibly a multi-IS256 system as selective advantages.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27741255 PMCID: PMC5065196 DOI: 10.1371/journal.pone.0164168
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Relevant characteristics of MRSA strains.
| Isolation | Strain | Isolation year | Genotype: | Gene for toxin | Resistance | Patient | Reference | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| country, | ST, | β-lactam agent | Non β-lactam agent | Disease | Outcome | Age | Sex | ||||||
| region, | SCC | MIC (μg/ml) | |||||||||||
| city | OXA | IPM | |||||||||||
| Russia | |||||||||||||
| Siberian | K | OC1 | 2010 | 8, 1 (t008), 1, IVc | 32 | 0.13 | G, K, E Cl, L, Ch, Su | Skin abscess | R | 50Y | F | 40 | |
| OC1C | 2011 | 8, 1 (t008), 1, IVc | 32 | 0.25 | L, Ch | Colitis | R | 3Y | M | 40 | |||
| OC8 | 2007 | 8, 1 (t008), 1, IVc | 32 | 0.25 | L, Ch | Pneumonia (CAP) | D | 1Y | M | 40 | |||
| OC11 | 2007 | 8, 1 (t008), 1, IVc | 32 | 0.25 | L, Ch | Pneumonia, sepsis | D | 39Y | M | 40 | |||
| OC22 | 2008 | 8, 1 (t008), 1, IVc | 32 | 0.5 | L, Ch | Pneumonia (CAP) | D | 41Y | M | 40 | |||
| OC23 | 2008 | 8, 1 (t008), 1, IVc | 64 | 0.13 | L, Ch | Pneumonia (CAP) | D | 40Y | M | 40 | |||
| OC52 | 2008 | 8, 1 (t008), 1, IVc | 32 | 0.25 | L, Ch | − | − | 34Y | F | 40 | |||
| OC59 | 2008 | 8, 1 (t008), 1, IVc | 32 | 0.13 | G, K, L, Ch | Pneumonia | D | 4M | F | 40 | |||
| OC160 | 2011 | 8, 1 (t008), 1, IVc | 32 | 0.5 | G, K, E, Clind, L, Ch | Wound infection, cellulitis | R | 53Y | M | 40 | |||
| OC217 | 2010 | 8, 1 (t008), 1, IVc | 32 | 0.13 | L | − | − | 19Y | F | 40 | |||
| OC3 | 2007 | 239, 3 (t037), 1, IIIA | ≥256 | 64 | G, K, E, Cl, L, T, Ch, | Pneumonia (HAP), sepsis | D | 46Y | M | 40 | |||
| R, Su, St | |||||||||||||
| European | M | M79 | 2011 | 8, 1 (t008), 1, IVc | 32 | 0.25 | G, K, L | Wound infection | R | 20-60Y | − | This study | |
| M185 | 2008 | 8, 1580 (t2648), 1, IVc | 32 | 0.25 | G, K, E, Cl, L, Ch | Sepsis | D | 20-60Y | − | This study | |||
| M257 | 2012 | 8, New (t1259), 1, IVc | 64 | 0.25 | E, Cl, L, Ch | − | − | 20-60Y | − | This study | |||
| S2 | 2011 | 8, 1 (t008), 1, IVc | 64 | 0.25 | G, K, L, Ch | Burn wound | R | 20-60Y | − | This study | |||
| S14 | 2011 | 8, 363 (t024), 1, IVc | 64 | 1 | G, K, E, Cl, L, Ch | Burn, sepsis | R | 20-60Y | − | This study | |||
| S65 | 2011 | 8, 1 (t008), 1, IVc | 64 | 0.25 | L, Ch | Wound, osteomyelitis | R | 20-60Y | − | This study | |||
| S214 | 2012 | 8, 363 (t024), 1, IVc | 64 | 4 | G, K, L, Ch | Osteomyelitis, pneumonia (HAP) | D | 20-60Y | − | This study | |||
| Y | Y269 | 2011 | 8, 1 (t008), 1, IVc | ≥256 | 16 | G, K, E, Cl, L, Ch | Wound infection | R | 20-60Y | M | This study | ||
| Far Eastern | V | 12K | 2008 | 8, 826 (tUK) | 32 | 0.06 | G, K, Ch | Urethritis | R | 21Y | M | 41, this study | |
| 40K | 2008 | 8, 826 (tUK) | 32 | 0.06 | G, K, E, Cl, Ch | Wound infection | R | 19Y | M | 41, this study | |||
| RF57 | 2006 | 8, 826 (tUK) | 64 | 1 | G, K, E, Cl, Ch, R | Wound infection | R | 20-60Y | − | 41, this study | |||
| RF570 | 2010 | 8, 826 (tUK) | 64 | 1 | G, K, E, Cl, Ch, R | Nosocomial respiratory tract infection | R | 20-60Y | − | This study | |||
| 16K | 2008 | 239, 351 (t030), 1, IIIR | ≥256 | 64 | G, K, E, Cl, L, T, Ch, R, Su, St | Urethritis | R | 20Y | M | 41, this study | |||
| USA | USA300-0114 | - | 8, 1 (t008), 1, IVa | PVL+ | 32 | 0.13 | K, E, Cii, T | - | - | - | - | 11, 42, 43 | |
aCity: K, Krasnoyarsk; M, Moscow; S, St. Petersburg; Y, Yaroslavl; V, Vladivostok. SCCmec: IVc, IV.3.1.2; IVa, IV.1.1.1; IIIA, III.1.1.2; IIIR, III.1.1.4. spa type: tUK (Unknown), unknown Ridom spa number. Gene: psmα(↑), elevated psmα expression (which was significantly higher than HA-MRSA expression levels, P<0.05). Other common adhesin genes include lukE-lukD, hla, hlg, hlg-v, hld, split hlb, and c12ag (icaA, icaD, eno, fnbA, fnbB, ebpS, clfA, clfB, fib, sdrC, sdrD, sdrE). PVL, Panton-Valentine leukocidin; ACME, arginine catabolic mobile element. Antimicrobial agent: OXA, oxacillin; IPM, imipenem; G, gentamicin; K, kanamycin; E, erythromycin; Cl, clindamycin; L, levofloxacin; Ci, ciprofloxacin; T, tetracycline; Ch, chloramphenicol; R, rifampicin; Su, sulfamethoxazole; St, streptomycin; Resistance: ind, inducible resistance; i, intermediate. Pneumonia: CAP, community-acquired pneumonia; HAP, hospital-acquired pneumonia. Outcome: R, recovery; D, death. Age: Y, year; M, month. Sex: F, female; M, male.
bLevofloxacin-resistant strains were also resistant to ciprofloxacin.
cHealthy carrier case (hospital worker).
dHealthy carrier case (student).
eFull personal (patient) information, not available.
fPrevious name, 57H.
gNo description.
Fig 1Pulsed-field gel electrophoresis (PFGE) analysis (A) and phylogenetic The MRSA strains shown are those described in Table 1. In A, strains were classified into two major groups: IN, those with a megabase inversion, and non-IN, those without a megabase inversion. The geographical location of MRSA isolation is colored: yellow, European Russia (Moscow, St. Petersburg, and Yaroslavl); red, Siberian Russia (Krasnoyarsk); green, Far Eastern Russia (Vladivostok). Square, isolated from a fatal case; asterisk, isolated from a healthy carrier. tUK, tUnknown (unknown Ridom spa number). Lvx, levofloxacin; Rif, rifampicin. In B, spa allele numbers and Ridom spa repeat numbers (in parentheses) are both shown. spa1(t008) represents the ancestral spa type for Russian ST8/SCCmecIVc MRSA; other spa types diverged directly from the common ancestral type. Lvxs, levofloxacin-susceptible; Rifs, rifampicin-susceptible; Lvxr, levofloxacin-resistant; Rifr, rifampicin-resistant.
Fig 2OC8 circular genome map (A) and genetic status of IS In A, OC8 genome information includes MRSA-typing targets, phages, SaPIs, mobile genetic elements, including IS256, virulence, drug resistance, and inversion. Genes (products) described on the genome map are: spa, protein A; coa, coagulase; psmα, phenol-soluble modulin α (cytolytic peptide); rsp, AraC family transcriptional regulator; rot, repressor of toxins; ebh, extracellular matrix-binding protein (very large surface-anchored protein/giant protein); grl, DNA topoisomerase IV (quinoplone resistance); hla, α-hemolysin (Hla); map, map protein; hld, δ-hemolysin (Hld); agr, accessory gene regulator; fos, fosfomycin resistance protein; tca, teicoplanin resistance-associated membrane protein; sbi, IgG-binding protein; hlg, γ-hemolysin (Hlg); fnb, fibronectin-binding protein; ica, intercellular adhesion protein A (biofilm formation); gyr, DNA gyrase (quinoplone resistance). The staphylococcal complement inhibitor (SCIN) gene (scn), staphylokinase (SAK) gene (sak), and superantigen SEA gene (sea) were carried by phage Sa3, and the β-hemolysin (Hlb) gene (hlb) was split by a phage Sa3 insertion. The OC8 genome carried 19 copies of IS256; they are numbered (① to ⑲), as shown in the figure. IS256-enriched hot spots are marked in pink. A large genomic inversion (MbIN), relative to USA300 FPR3757 (GenBank accession number CP000255), occurred between IS256⑤ and IS256⑰; the inverted region is marked with a red thick arrow. Due to MbIN, the genomic island vSAβ, which carried three IS256 (⑥, ⑰, and ⑱), was split into two parts located far from each other. In B, the direction of the IS256 insertion is shown by arrows. Attachment (att) site sequences appear on both sides of IS256 as direct repeats (DRs) upon insertion [48,49]; the att sequences of 19 IS256 copies were all divergent from each other. The att sequences in capital letters were present as att at the corresponding position of USA300 FPR3757, which lacked IS256. Regarding unusual att sets, the red mark (box) indicates heterogeneous att sequences on the left and right sides, and the green mark indicates the imperfect DRs of att. The 26-bp imperfect terminal inverted repeats of IS256 were identical for 19 IS256 copies, except for IS256③, which had one base change.
Fig 3Sequence comparison between OC8 and USA300 FPR3757 genomes and visualization of a large genomic inversion.
Genomic sequence comparisons were performed using WebACT for the visualization of genomic inversions. The genome sequence of USA300 FPR3757 was from GenBank Accession number CP000255. The OC8 inverted region relative to USA300 FPR3757 is highlighted in blue.
Fig 4The structure of IS256 and its extrachromosomal circular DNA in OC8.
In A, the structure of IS256 (OC8) is based on the OC8 genome sequence (GenBank accession number AP017377); the structure was very similar to previously described IS256 structures [27,48,49]. PCR primers to detect an IS256 circular DNA were designed based on the OC8 genome sequence. In B, the PCR primer set (R-R1 and L-R2, shown in A) exactly detected IS256 circular DNA for OC8 (PCR product size, approximately 200 bp), while there were no amplified bands for strain USA300-0114, which lacked IS256. In C (and B), the 194-bp nucleotide sequence of the estimated PCR product, perfectly matched the IRL side and IRR side regions of IS256 (OC8), and contained a 6-bp stretch, marked in red; 26-bp imperfect IR sequences and 6-bp stretch sequences were underlined in C. However, the 6-bp stretch data showed a “mixed” result, with TTTTTT as the highest base content (followed by AAAAAA). Since the 6-bp stretch originates from a flanking att sequence [48] and OC8 carries 19 IS256 copies with distinct att sequences, the “mixed” 6-bp stretch reflects the presence of heterogeneous circular DNA (in terms of stretch sequences) in OC8. This observation is consistent with the AT-rich att sequences of 19 IS256 copies on the genome.
Fig 5Possible mechanisms for the large genomic inversion in OC8.
In this model, shown in A, we hypothesized ancestor strains of OC8 for a one-megabase inversion (MbIN) and simultaneously-occurring deletion events. An initial ancestor strain (OC8 ancestor 1) lacks IS256, but has att site sequences, similar to USA300 FPR3757 (GenBank accession number CP000255); the size of OC8 ancestor 1 DNA flanked by two att sites on the right side of the figure was estimated to be 3,356 bp. The first step (step 1) includes three IS256 insertions at different att sites. As shown on the right side of the figure, a homogenous recombination (step 2) then occurs between the direct repeats of IS256 (in OC8 ancestor 1a), deleting a small region and leaving only one copy of IS256 (generating OC8 ancestor 2). In step 3, a homogenous recombination subsequently occurs between the inverted repeats of IS256 (on OC8 ancestor 2), with the one-megabase region being inverted, and generating OC8. The genes of NTPase, hsdS, and hsdM (on the top right side) were located in the genomic island vSAβ (marked with a red line). In B, figures focus on a vSAβ split event, which occurred simultaneously with MbIN. OC8 ancestor 1, OC8 ancestor 2, and OC8 are the same as those described in A. In C, a hypothetical folded chromosome structure with loop domains is illustrated, based on [57], to boost the crossover and subsequent MbIN events at the two genomic locations, which are far from each other. (The diagram is not to scale.)
Fig 6PCR targeting the OC8-type megabase inversion (MbIN).
In A and B, PCR primers targeting the junction sites of OC8 MbIN (A-C and B-D) and those targeting the corresponding region of USA300 FPR3757 (A-B and C-D) were designed based on the OC8 or USA300 FPR3757 complete genome sequence, respectively. The structures of the MbIN junction regions of OC8 and the corresponding regions of USA300 FPR3757 are from Fig 5. In C to E, PCR products with an asterisk were sequenced, and the sequences determined were consistent with the OC8 or USA300 FPR3757 genome sequence. ST8Kras is ST8/SCCmecIVc MRSA from Krasnoyarsk, Siberian Russia. The geographical location of MRSA isolated in European Russia: Mow, Moscow; St. P, St. Petersburg; Yar, Yaroslavl. Regarding Far Eastern Russia, MRSA was isolated in Vladivostok.